Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Business



The Business Content Channels contain Press Releases about
Filter     Order     Display # 
Date Item Title Hits
11 Feb 2010 ABLYNX WINS PATENT OPPOSITION CASE AGAINST DOMANTIS (GSK) 468
14 Jan 2010 Affimed Therapeutics AG completes move into drug development 363
24 Nov 2009 Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility 569
23 Nov 2009 Merck KGaA to Expand Research and Development Presence in China 346
17 Nov 2009 deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 393
11 Nov 2009 YSIOS, LSP and VENTECH led this financing round together with Genetrix and also joined by new investors 427
10 Nov 2009 BioVex Completes $70 Million Financing to Conclude Pivotal Study With Its Pioneering Cancer Treatment, OncoVEX (GM-CSF) 375
05 Nov 2009 GENMAB REORGANIZES TO BUILD SUSTAINABLE BUSINESS 437
18 Sep 2009 Novo Nordisk opens new research centre in Seattle 733
20 Aug 2009 ZymoGenetics Submits Citizen Petition to FDA Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety 763
13 Aug 2009 Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information 573
19 Jun 2009 GTC Biotherapeutics Enters Agreements with LFB for Funding of $12.3 Million with an Option for LFB to Fund an Additional $6.4 Million 686
17 Jun 2009 Biogen Idec Announces Conclusion of Arbitration with Genentech 508
08 Jun 2009 Sanofi-aventis to purchase Diabel manufacturing facility in Frankfurt to strengthen Insulin Production Capacities 621
12 May 2009 Sanofi-aventis builds a New Vaccine Manufacturing Facility in France with an investment of 350 million euros 709
05 May 2009 Sanofi-aventis converts its Vitry-sur-Seine Industrial Facility to Biotechnologies 657
29 Apr 2009 ZymoGenetics Announces Workforce Reduction and Restructuring 477
28 Apr 2009 BioXell announces restructuring following review of portfolio 532
22 Mar 2009 Merck KGaA Launches Strategic Venture Capital Fund 977
19 Mar 2009 Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization 615
17 Mar 2009 Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says 621
15 Mar 2009 Astellas to Terminate Offer for CV Therapeutics 867
09 Mar 2009 Sanofi-aventis invests €100 million in new facility in Mexico to produce seasonal and pandemic influenza vaccine 403
24 Feb 2009 Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring 718
11 Feb 2009 Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center 977
29 Jan 2009 Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash 979
26 Jan 2009 Basilea Pharmaceutica focuses on commercialization of its products and high priority programs 883
22 Jan 2009 UCB to divest selected smaller markets to further focus on its key strategic areas 836
22 Jan 2009 Celestial Biologicals collaborates with GE Healthcare to set up India's first fully integrated chromatography-based plasma fractionation facility 511
21 Jan 2009 Lexicon Consolidates Operations to Focus Resources On Most Advanced Drug Discovery and Development Programs 730
18 Jan 2009 MorphoSys Provides Update on Pipeline Activities in 2009 716
15 Jan 2009 XOMA Announces Workforce Reduction 849
14 Dec 2008 EntreMed Focuses on Development of ENMD-2076 4201
07 Dec 2008 Emisphere Announces Reorganization Plan to Strengthen Financials and Focus On Technology Application 1522
01 Dec 2008 Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 1328
26 Nov 2008 Arpida to restructure and focus on key projects 1116
26 Nov 2008 Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist 856
19 Nov 2008 ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production 1515
18 Nov 2008 Orion to renew operational model of pharmaceutical R&D. Negotiation proposal on reduction of up to 300 employees in Finland 828
18 Nov 2008 Sanofi-aventis Announces the Settlement of Nasacort(R) AQ U.S. Patent Litigation and Certain Allegra(R)/Allegra(R) D-12 U.S. Patent Litigations 955
11 Nov 2008 Merck Serono Launches Expansion of Flagship Biotech Center to Meet Growing Patient Needs 902
10 Nov 2008 Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction 750
10 Nov 2008 ASKA Pharmaceutical and Actavis Group announce business alliance and joint venture in generic medicines in Japan 1217
09 Nov 2008 XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122 882
06 Nov 2008 Novo Nordisk invests close to 400 million US dollars in new insulin production plant in China 872
22 Oct 2008 EPIX Pharmaceuticals Announces Reduction in Force 807
22 Oct 2008 Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy 695
22 Oct 2008 Gates Foundation Invests in 104 Novel Ideas for Global Health 722
20 Oct 2008 Sanofi-aventis expands its R&D presence in China 1485
19 Oct 2008 SemBioSys announces substantial cost reductions to extend development runway 700
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 50 of 72

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

Oncology Market Leaders
Order Now

Subscribe La Merie Biologics